Hernan Antonio Bazan MD DFSVS, FACS (He/Him)
Clinical Pharmacology, Clinical Informatics
Chief of Vascular & Endovascular Surgery, California Pacific Medical Center - Sutter Health | San Francisco, CA
Join to View Full Profile
1100 Van Ness AveFl 5San Francisco, CA 94109
Phone+1 415-537-8600
Dr. Bazan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hernan Bazan is a Vascular/Endovascular Surgeon based in San Francisco, CA, with subspecialties biotech and clinical Informatics. He completed his vascular surgery fellowship at Yale-New Haven Medical Center and a surgery residency at Icahn School of Medicine at Mount Sinai. His expertise includes peripheral vascular disease, aortic aneurysm, and carotid stenosis. Dr. Bazan has published several studies in esteemed journals and has been involved in clinical trials focusing on carotid stenosis and critical limb ischemia. He has received recognition, including a Trailblazer Award from the NIH Director's HEAL initiative and multiple "Top Doctor" honors from Castle Connolly.
Education & Training
Yale-New Haven Medical CenterFellowship, Vascular Surgery - Independent, 2005 - 2007
Icahn School of Medicine at Mount SinaiResidency, Surgery, 2000 - 2005
Georgetown University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2025 - 2027
LA State Medical License 2007 - 2026
CT State Medical License 2006 - 2008
American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- Trailblazer Award NIH Director's HEAL (Helping to End Addiction Long Term), 2024
- Top Doctor in Vascular Surgery Castle Connolly, 2014, 2020-2024
- Distinguished Fellow Society for Vascular Surgery (SVS), 2020
Clinical Trials
- Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia Start of enrollment: 2014 Aug 01
- Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial Start of enrollment: 2014 Dec 09
- The CREST-2 Registry
Publications & Presentations
PubMed
- Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus.Angelle Bradford, Tadashi Yoshida, Sergiy Sukhanov, Foster F Woods, Patrice Delafontaine
Journal of Molecular and Cellular Cardiology Plus. 2025-12-01 - 1 citationsA non-toxic analgesic elicits cell-specific genomic and epigenomic modulation by targeting the PAG brain region.Hernan A Bazan, Brian L Giles, Surjyadipta Bhattacharjee, Scott Edwards, Nicolas G Bazan
Neurobiology of Pain. 2025-07-20 - Precision in Stroke Care: Novel Model for Predicting Functional Independence in Urgent Carotid Intervention Patients.Hernan A Bazan, Daniel Fort, Larry Snyder, Frank G Opelka, Samuel R Money
Journal of the American College of Surgeons. 2025-04-01
Authored Content
- The Fentanyl Crisis and the Lack of Pain Management AlternativesDecember 2024
- Invited CommentaryNovember 2018
Press Mentions
Data-Driven Tool Helps Direct Decision-Making for Stroke PatientsApril 23rd, 2025- HMN 2025: How New Software Predicts Stroke Consequence with 93% Accuracy, Guiding Higher Carotid Surgical Procedure ChoicesJanuary 30th, 2025
- Ochsner Team Develops 93% Accurate Predictive Model for Stroke PatientsJanuary 29th, 2025
Grant Support
- Novel non-narcotic analgesic for acute and chronic painNINDS, NIH - SBIR Commercialization Readiness Pilot (CRP) Program, Small business development grant2023–2025
- Non-coding RNAs as Diagnostic Targets for Diabetic RetinopathyEye, Ear, Nose & Throat (EENT) Foundation2022–2025
- Elucidating Mechanisms of Carotid Plaque Rupture Resulting in Stroke with Biobank and Qualitative Data SupportOchsner Health Cardiovascular Disease Translational Research Grant2023–2024
- Novel non-narcotic analgesic for acute and chronic painNINDS, NIH2020–2023
- Inflammatory Mediators LEAD To Carotid Plaque Instability And RuptureNational Center For Research Resources2008–2009
Professional Memberships
- Member
- Member
- Biotechnology Innovation Organization - BIOMember
- Southern Association for Vascular Surgery - SAVSMember
- Yale Surgical SocietyMember
Other Languages
- Spanish
Industry Relationships
- CEO & Co-Founder, South Rampart Pharma, Inc.South Rampart Pharma, Inc. is a clinical-stage life science company focused on advancing innovative small molecules designed to overcome the risks of current pain medicines.2016 - Present
External Links
- LinkedIn - H Bazan, MDhttp://www.linkedin.com/in/hernan-bazan-md-dfsvs-facs-92b5a6b0
- LinkedIn - South Rampart Pharma, Inc.https://www.linkedin.com/company/south-rampart-pharma-llc/?viewAsMember=true
- Google Scholarhttps://scholar.google.com/citations?hl=en&user=zBZOR-cAAAAJ&view_op=list_works&sortby=pubdate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
